SWM
AVNS

Spire Wealth Management’s Avanos Medical AVNS Stock Holding History

Spire Wealth Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-121
Closed -$1.4K – 2312
2025
Q3 		$1.4K Sell
121
-215
-64% -$2.52K ﹤0.01% 2217
2025
Q2 		$4.11K Sell
336
-226
-40% -$2.84K ﹤0.01% 2009
2025
Q1 		$8.05K Buy
562
+527
+1,506% +$8.23K ﹤0.01% 1906
2024
Q4 		$557 Hold
35
– – ﹤0.01% 2432
2024
Q3 		$841 Buy
35
+4
+13% +$91 ﹤0.01% 2114
2024
Q2 		$618 Hold
31
– – ﹤0.01% 2173
2024
Q1 		$617 Hold
31
– – ﹤0.01% 2274
2023
Q4 		$586 Hold
31
– – ﹤0.01% 2344
2023
Q3 		$627 Hold
31
– – ﹤0.01% 2321
2023
Q2 		$792 Sell
31
-1
-3% -$26 ﹤0.01% 2338
2023
Q1 		$952 Hold
32
– – ﹤0.01% 2396
2022
Q4 		$1K Hold
32
– – ﹤0.01% 2141
2022
Q3 		$1K Sell
32
-12
-27% -$314 ﹤0.01% 2040
2022
Q2 		$1K Buy
44
+12
+38% +$345 ﹤0.01% 2460
2022
Q1 		$1K Buy
32
+1
+3% +$32 ﹤0.01% 2452
2021
Q4 		$1K Sell
31
-2
-6% -$65 ﹤0.01% 2846
2021
Q3 		$1K Hold
33
– – ﹤0.01% 2516
2021
Q2 		$1K Sell
33
-3
-8% -$124 ﹤0.01% 2525
2021
Q1 		$2K Buy
+36
New +$1.69K ﹤0.01% 2824

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Spire Wealth Management's AVNS Position: Q4 2025 in Review

Spire Wealth Management sold out of Avanos Medical (AVNS) in Q4 2025, closing a stake of 121 shares — an estimated $1.4K sold.

Spire Wealth Management first reported a position in AVNS in Q1 2021 and held it in 19 quarters. The position peaked at $8.05K in Q1 2025. 274 funds tracked by Wall St. Rank hold AVNS as of Q4 2025.

  • Spire Wealth Management reported no remaining Avanos Medical position as of Q4 2025 after selling out during the quarter.
  • Spire Wealth Management sold 121 Avanos Medical shares in Q4 2025, an estimated $1.4K.
  • Spire Wealth Management first reported a position in Avanos Medical in Q1 2021 and held it in 19 quarters.
  • Spire Wealth Management's Avanos Medical position peaked at $8.05K in Q1 2025.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2025.

Based on Spire Wealth Management's 13F filing for Q4 2025, filed 14 Jan 2026.